Abstract information

 

The Abstract Submission for EULAR 2014 in Paris is now closed.  

 

Abstract notifications for EULAR 2014 have been sent out to the corresponding author.

Should you not have received the notification, the status of your abstract can also be checked by the submitter and account holder by logging in to the B-Com account used for the submission following this link >>

https://b-com.mci-group.com/Portal/Abstract/Submission/Default.aspx?EventCode=EULAR2014&PortalCode=EULAR


Contact in case of questions: eular.abs@mci-group.com


GENERAL
Abstracts can only be submitted online via the online abstract submission system. Abstracts sent by post or email will not be accepted. No exceptions will be made.

 

TECHNICAL REQUIREMENTS
The internet abstract submission system works best with Internet Explorer 7.0 or higher and Mozilla Firefox 3.0 or higher.
Cookies and JavaScript need to be enabled

 

Please read this information carefully!

  • Abstract submission must be in one of the three different categories:
    a. Medical or Research Professional / Clinician
    b. Health Professional in Rheumatology / Practice and Research
    c. PARE Member / Patient

    The categories are subdivided into topics (Abstract topics >>).
    The correct category and topic must be selected to ensure correct scoring. The content of the abstract must be topic related.
  • Please carefully read all instructions in the abstract submission system before preparing your abstract.
  • For standardisation, the acceptable length of the abstract is not more than 3600 characters and 50 lines, author's details and headers included. This also includes non-visible characters such as spaces and punctuation.
  • The abstract should be structured into the following sections:
    a. A title which clearly indicates the nature of the investigation
    b. Background
    c. Objectives
    d. Methods
    e. Results
    f. Conclusions
    g. References
  • One graph/image can be included with the following criteria:
    Image width: min. 50 pixels - max. 750 pixels
    Image height: min. 50 pixels - max. 750 pixels
    Image quality: min. 96 dpi - max. 300 dpi
    Image file size: min. 35 KB - max. 1000 KB
    Allowed file type: gif, jpg
    Please note that insertion of graphs and images may significantly reduce the number of remaining allowed characters.
  • Abstracts can be saved in "Draft" status to be finalised until the submission deadline (31 January 2014, 23:59 CET). Therefore, the submitter will be required to create a user account.
  • Abstracts fulfilling all criteria can be saved in "Final submission" status. Only abstracts in "Final submission" status will be regarded as successfully submitted and considered for the congress. Abstracts in "Final submission" status can be re-edited and modified until the submission deadline
    (31 January 2014, 23:59 CET).
  • An abstract can only be submitted if the "Rules and Regulations", including the "EULAR embargo rules" are read and accepted.
  • Conflict of interest: It is the intent of EULAR to provide high quality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstracts submission.
  • Abstracts accepted for the congress are subject to the "Abstract Embargo Rules" and the "Transfer of Copyright". With the submission of an abstract the authors agree to the embargo rules and the transfer of copyright. Please note the links in the right column.
  • The corresponding author has the right to grant, and does grant, on behalf of all authors an exclusive licence on a worldwide basis to the BMJ Publishing Group Ltd and EULAR to publish the abstract (if accepted) in any media and to exploit all subsidiary rights.
  • Should the abstract be selected for oral presentation, the authors, represented by the presenting author, grant EULAR the right to  record the entire presentation (audio and slide) and subsequently use it for educational purposes. Further information will be available on this page of the EULAR website at a later stage
  • Only abstracts that contain original data can be submitted.
  • Abstracts should not be submitted if the following applies:
    • the abstract contains data that has been published or accepted for publication in a print or on-line journal.
    • the abstract contains data that was presented at a scientific meeting more than 12 months prior to EULAR 2014
  • Abstracts containing data that has been presented or will be presented at a different scientific meeting during a 12 months period prior to EULAR 2014 can be submitted. This fact must be indicated on the submission form.
  • Abstracts having been submitted for publication or to a scientific meeting, but are pending acceptance, can be submitted without restrictions. However, once the abstract has been accepted by EULAR it is automatically subject to the EULAR embargo rules.
  • The reviewers will judge the abstracts according to the scientific or clinical value, relevance to EULAR, suitability of methods to aims, conclusions confirmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.
  • Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done.
  • Accepted abstracts will be published in a supplement to the Annals of Rheumatic Diseases. Information on accepted abstracts will also be available on-line on the EULAR website about one month prior to the congress. Published abstracts will be available in the EULAR Abstract Archive after the congress.
  • The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and the time assigned by the EULAR Scientific Committee. We therefore recommend that submitters of abstracts register for the congress simultaneously with abstract submission.
  • Abstracts not adhering to these guidelines will be rejected. If you do not agree with any of these rules, you should not submit an abstract. The final decision about acceptance of an abstract will be taken by the EULAR Scientific Committee. EULAR does not correspond on the acceptance/rejection of an abstract.
  • If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to the EULAR Secretariat or MCI not later than 1 April 2014.
Instructions for abstract presentations
  • If an abstract is selected for oral presentation, the presenting author as specified at submission will be requested to present it in the assigned session. Details will be communicated to the author by mid-April 2014.
  • If an abstract is accepted as a poster presentation, the presenting author will be requested to be available for discussion during the corresponding poster viewing session.

  • Posters will be set up close to the exhibition area.
  • Please use letters large enough to be read from a distance of 1.5 meters.



RELATED INFORMATION

 

Abstract submission system closed

The abstract submission is now closed. Thank you for your submissions

 

Abstract submission deadline
was 31 January 2014 23:59 CET
Abstracts received after the deadline were not be accepted!

 

Notifications to submitters
mid-April 2014

 

Online publication of abstracts information 
Read >>

 

Abstract embargo rules (pdf)

Read >> 

 

Information for poster presenters

Read >>

 

Information for oral abstract  presenters

Read >>


Information for Poster Tour Presenters

Read >>


Grant of publishing licence (pdf)

As part of your submission, you grant EULAR and BMJ the exclusive right of publishing.

Read the full agreement >>

  

For further information
please contact
eular.abs@mci-group.com